about
Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?Body temperature regulation in diabetesPancreatic β Cell Mass DeathSex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusRisk Factors for Fatal Hyperglycaemia Confirmed by Forensic Postmortem Examination - A Nationwide Cohort in SwedenHuman genetics as a model for target validation: finding new therapies for diabetes.Epidemiology of Fractures in Diabetes.Change in life expectancy with type 2 diabetes: a study using claims data from lower Saxony, GermanyA comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes.The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trialsIntroduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.Diabetes in the elderly.Appraisal of clinical practice guidelines for management of paediatric type 2 diabetes mellitus using the AGREE II instrument: a systematic review protocol.Type 2 Diabetes Genetic Predisposition, Obesity, and All-Cause Mortality Risk in the U.S.: A Multiethnic Analysis.Glucose-lowering therapy in type 2 diabetes. New hope after the EMPA-REG outcome trialClinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsBlood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study.Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013.Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling.Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, ChinaDiabetes and Cause-Specific Mortality in Mexico City.Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank JapanSurvival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort.Disease drivers of aging.Overweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetesLower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose CotRisk of cause-specific death in individuals with cancer - modifying role diabetes, statins, and metformin.OP449 inhibits breast cancer growth without adverse metabolic effects.Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT).Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.Shared decision-making in the care of individuals with diabetes.Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014.
P2860
Q26740253-59FE2DDC-CD62-458E-8760-EB38CCCD9931Q26745765-72799FC8-8F0B-437B-A024-4D7BE505432DQ26752571-2E74AF22-5CC3-463A-8D39-C738DBC360B7Q28395801-28D00C4B-E979-4BFD-BC75-7BD8CC8332E7Q28552857-D20B7A5A-CA83-4684-848C-E7AA18F90292Q30234640-FC582CD7-56BD-4896-96E5-88A683AAF005Q30248863-AF94C08C-112D-4295-B676-27BD5C8553F0Q31161569-DDB1BA2C-5B5C-4C00-BBE8-0CFC15A72B4DQ33560279-8DA05CFA-C64B-49D0-A399-3A581CCEB9F0Q33768328-34D89989-FE81-4EF7-BCF9-32D460C09169Q33801801-EF3A5453-7628-4776-A651-EF7773660EC1Q33814542-78176264-9A4A-49FE-80C3-0E6AED524966Q33903514-290AD549-4550-47DF-A565-1E6DAD2AE0AAQ36076695-C87EBBD5-8989-41E4-BAD8-AC56B5499C90Q36726180-3C55571D-C87B-4A41-888E-22954A1612E6Q36820255-F05682EA-DD60-4BCB-898A-C4D0335C8B47Q36989711-7A78304A-1754-4A2A-898D-13F56BA69944Q37011769-C83A6940-C98D-412B-96C3-04739AA91067Q37154677-19F8F2B3-D3B6-4338-BA92-8A4F6974B5E6Q37236907-DEEB3FBF-3752-48A4-A5F0-E3F98C1C57E5Q37242959-63040043-00E8-470D-B9C9-7350B95FD162Q37251203-DEEF792A-EC56-4EFF-92AD-5B9CA53B1452Q37279013-67CE6249-D74C-4522-A0BF-E39049F399FFQ37526163-55A9E72B-9493-4603-BD8A-25E8B8C2F419Q37559975-1B47BF58-3940-4726-A1AC-BA30C3D1432BQ37700205-4E9A1E65-93A0-44DE-84EA-5A1D69510050Q37700228-E64C779F-D6DD-4C0B-94C5-B9CC4DDAA914Q37730342-42EDCB43-2597-4484-A2ED-F47AE2209328Q37730348-DEB495AB-7D84-4F89-90A9-6E802D7C2236Q38376619-91A680A2-677C-4073-B64A-2AF2EDEECCCAQ38398847-E7743B5B-F9A5-4DE3-9DC4-CE8EA649C600Q38613399-B560715F-10AD-47D3-AECE-2B65757349DBQ38629283-48EE9E49-DB7C-47CD-A53C-F67860A83552Q38661153-CBDDCBF0-84C5-4281-88C0-743E07453CD0Q38677505-5C116E05-1DFB-4002-968C-934F07309121Q38690284-3130B2C5-1B00-44AB-81AA-B78FD2D08448Q38741915-956DA787-5DE7-4C67-A9CE-020E098169CEQ38786133-2A1C4EA8-4BB8-4075-8A8F-EDEB71B603BEQ38814949-4D1B617C-36F3-4FE0-8214-91C1F152B956Q38848552-BACAA69E-A9D6-480A-BD27-2DA6B267D8CB
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Excess Mortality among Persons with Type 2 Diabetes.
@en
type
label
Excess Mortality among Persons with Type 2 Diabetes.
@en
prefLabel
Excess Mortality among Persons with Type 2 Diabetes.
@en
P2093
P356
P1476
Excess Mortality among Persons with Type 2 Diabetes.
@en
P2093
Aldina Pivodic
Ann-Marie Svensson
Hans Wedel
Marcus Lind
Mark Clements
Mauro Tancredi
Mikhail Kosiborod
Sofia Dahlqvist
P304
P356
10.1056/NEJMOA1504347
P407
P577
2015-10-01T00:00:00Z